How to Read Your Bloodwork — Complete Biomarker Guide for Research Compound Users

Understanding your bloodwork is the most important skill any research compound user can develop. Whether you're running testosterone, oral compounds, or complex protocols, your blood panels tell the complete story of what's happening inside your body.

This comprehensive guide breaks down every biomarker you need to monitor, what the numbers mean, and when to be concerned. By the end, you'll read bloodwork like a pro and make informed decisions about your research protocols.

Why Bloodwork Matters More Than You Think

Research compounds affect multiple body systems simultaneously. While you might feel fine subjectively, silent issues can be brewing underneath:

• Liver stress from oral compounds
• Cardiovascular strain from altered lipid profiles
• Kidney dysfunction from elevated blood pressure
• Hormonal imbalances affecting long-term health

Studies show that 73% of steroid users never get bloodwork, yet post-cycle recovery issues are directly linked to unmonitored biomarker changes during protocols.

The smart approach? Get baseline bloodwork before starting any research, monitor during protocols, and track recovery afterward.

Essential Bloodwork Panels for Research Users

#### Complete Blood Count (CBC)

Hemoglobin (Hgb): 13.8-17.2 g/dL (men)

• High levels indicate thickened blood (polycythemia)
• Common with testosterone and other androgens
• Levels >18 g/dL require immediate attention
• Solution: Therapeutic phlebotomy (blood donation)

Hematocrit (Hct): 41-50% (men)

• Percentage of blood volume occupied by red blood cells
• Elevated hematocrit increases stroke/heart attack risk
• Target: Keep below 52% during protocols
• Monitor every 6-8 weeks on longer cycles

Red Blood Cell Count (RBC): 4.7-6.1 million cells/mcL

• Tracks alongside hemoglobin and hematocrit
• Testosterone stimulates red blood cell production
• Elevated RBC creates "thick blood syndrome"

White Blood Cell Count (WBC): 3,500-10,500 cells/mcL

• Immune system function indicator
• Some compounds may suppress immune response
• Low WBC increases infection risk

#### Comprehensive Metabolic Panel (CMP)

Glucose: 70-99 mg/dL (fasting)

• Research compounds can affect insulin sensitivity
• Growth hormone and insulin protocols require close monitoring
• Elevated glucose indicates metabolic stress

Blood Urea Nitrogen (BUN): 6-24 mg/dL

• Kidney function indicator
• High protein diets and kidney stress elevate BUN
• Monitor especially with high blood pressure

Creatinine: 0.74-1.35 mg/dL (men)

• Primary kidney function marker
• Elevated levels indicate kidney stress or damage
• Some compounds increase creatinine through muscle breakdown

eGFR: >90 mL/min/1.73m²

• Estimated glomerular filtration rate
• Best overall kidney function assessment
• Values <60 indicate significant kidney impairment

ALT (SGPT): 7-56 IU/L

• Liver enzyme indicating hepatocyte damage
• Oral steroids commonly elevate ALT
• Levels >100 IU/L require protocol modification

AST (SGOT): 10-40 IU/L

• Another liver enzyme, also found in muscle tissue
• Intense training can elevate AST independently
• AST/ALT ratio helps distinguish liver vs. muscle source

Hormone Panel Deep Dive

#### Testosterone Markers

Total Testosterone: 264-916 ng/dL

• Primary androgen measurement
• Varies significantly with age and genetics
• Exogenous testosterone suppresses natural production

Free Testosterone: 9.3-26.5 pg/mL

• Biologically active testosterone not bound to proteins
• More accurate indicator of androgenic effects
• SHBG levels affect free testosterone calculations

Estradiol (E2): 7.6-42.6 pg/mL (men)

• Testosterone converts to estradiol via aromatase
• Low E2: Joint pain, low libido, mood issues
• High E2: Water retention, gynecomastia, emotional volatility
• Sweet spot: 20-30 pg/mL for most men

SHBG: 16.5-55.9 nmol/L

• Sex hormone binding globulin
• Lower SHBG increases free testosterone
• Oral steroids typically suppress SHBG
• Low SHBG can indicate liver stress

LH: 1.7-8.6 mIU/mL

FSH: 1.5-12.4 mIU/mL

• Luteinizing hormone and follicle-stimulating hormone
• Both suppressed during exogenous hormone use
• Recovery indicators post-cycle
• Should normalize 6-12 weeks after proper PCT

#### Lipid Profile Analysis

Total Cholesterol: <200 mg/dL (optimal)

• Combined LDL, HDL, and VLDL cholesterol
• Research compounds typically worsen lipid profiles
• Monitor every 6-8 weeks during protocols

LDL Cholesterol: <100 mg/dL (optimal)

• "Bad" cholesterol linked to cardiovascular disease
• Oral steroids particularly harsh on LDL
• Levels >160 mg/dL significantly increase heart disease risk

HDL Cholesterol: >40 mg/dL (minimum for men)

• "Good" cholesterol with protective effects
• Most research compounds suppress HDL
• HDL <30 mg/dL dramatically increases cardiovascular risk
• Target: Keep HDL >35 mg/dL during protocols

Triglycerides: <150 mg/dL

• Elevated levels increase pancreatitis and heart disease risk
• Growth hormone and insulin can elevate triglycerides
• Fasting 12+ hours required for accurate measurement

LDL/HDL Ratio: <3.5 (optimal)

• Better predictor of cardiovascular risk than individual values
• Ratio >5.0 indicates high cardiovascular risk

#### Thyroid Function

TSH: 0.27-4.2 μIU/mL

• Thyroid stimulating hormone
• High TSH indicates underactive thyroid
• Some compounds may suppress thyroid function

Free T4: 0.93-1.7 ng/dL

Free T3: 2.0-4.4 pg/mL

• Active thyroid hormones controlling metabolism
• T3/T4 protocols require careful monitoring
• Low thyroid function impairs recovery

Reading Your Results: Red Flags and Action Items

#### Immediate Concerns (Stop Protocol)

Liver Enzymes >3x Upper Normal Limit

• ALT >150 IU/L or AST >120 IU/L
• Indicates significant liver stress
• Discontinue oral compounds immediately
• Implement liver support protocol

Hematocrit >54%

• Dangerous blood thickness
• Immediate blood donation required
• Consider reducing testosterone dose

HDL <25 mg/dL

• Extremely high cardiovascular risk
• Reassess protocol immediately
• Implement aggressive lipid support

eGFR <60 mL/min/1.73m²

• Significant kidney impairment
• Medical consultation required
• Avoid nephrotoxic compounds

#### Warning Signs (Monitor Closely)

ALT/AST 2-3x Normal

• Moderate liver stress
• Add liver support supplements
• Consider oral compound dose reduction

Hematocrit 52-54%

• Elevated but not critical
• Increase blood donation frequency
• Monitor every 4 weeks

HDL 25-30 mg/dL

• Concerning but manageable
• Implement cardio protocol
• Consider lipid support supplements

Optimal Testing Schedule

#### Pre-Protocol Baseline

• Complete panel 2-4 weeks before starting
• Establishes personal normal ranges
• Identifies pre-existing issues

#### During Protocol

• Weeks 4-6: Mid-cycle assessment
• Week 8+: End of cycle (longer protocols)
• Focus on liver, lipids, and hematocrit

#### Post-Cycle Recovery

• 4 weeks post-PCT: Initial recovery check
• 8-12 weeks post-PCT: Full recovery confirmation
• Focus on hormone normalization

#### Annual Health Screen

• Comprehensive panel including cardiac markers
• Inflammation markers (CRP, homocysteine)
• Insulin sensitivity (HbA1c, HOMA-IR)

Supplement Support Based on Bloodwork

#### Elevated Liver Enzymes

• NAC: 600mg twice daily
• TUDCA: 250-500mg daily
• Milk thistle: 200mg standardized extract
• Reduce or eliminate oral compounds

#### Poor Lipid Profile

• Fish oil: 2-3g EPA/DHA daily
• Red yeast rice: 600mg daily
• Bergamot extract: 500mg daily
• Increase cardiovascular exercise

#### High Hematocrit

• Grapefruit seed extract
• Nattokinase: 100mg daily
• Increase water intake
• Regular blood donation

Working With Healthcare Providers

Many physicians lack experience with research compound users. Here's how to navigate medical consultations:

Be Honest About Usage

• Hiding compound use prevents proper care
• Bring your complete protocol history
• Request specific tests you need

Find Performance-Oriented Providers

• Sports medicine physicians
• Anti-aging/hormone clinics
• Telemedicine platforms specializing in male health

Prepare for Appointments

• Bring previous bloodwork for comparison
• List all compounds and dosages
• Ask specific questions about concerning values

Technology Tools for Tracking

#### Recommended Apps

• Lab Me Analytics: Upload and track bloodwork trends
• Steroids Cycle Calculator: Monitor compound timing
• MyFitnessPal: Track dietary factors affecting bloodwork

#### Spreadsheet Templates

Create tracking sheets including:

• Date, compound, dosage
• Bloodwork values with normal ranges
• Symptoms and side effects
• Intervention measures taken

Special Considerations for Common Compounds

#### Testosterone Protocols

• Monitor E2 levels closely
• Watch for polycythemia development
• Track LH/FSH suppression

#### Oral Steroids (Anavar, Dianabol, Winstrol)

• Liver enzymes every 4 weeks maximum
• Lipid profile deterioration common
• SHBG suppression affects hormone calculations

#### Trenbolone

• Kidney function monitoring essential
• Lipid profile severely affected
• May cause false glucose elevations

#### Growth Hormone

• IGF-1 levels for dosage verification
• Glucose tolerance monitoring
• Thyroid function assessment

Frequently Asked Questions

Q: How often should I get bloodwork during a 12-week testosterone cycle?

A: Baseline before starting, mid-cycle at week 6, and 4 weeks into PCT. This schedule catches issues early while avoiding excessive testing costs.

Q: My ALT is 87 IU/L on week 6 of an oral cycle. Should I be concerned?

A: Yes, this is elevated (normal <56). Add liver support immediately and retest in 2 weeks. If it continues rising, discontinue the oral compound.

Q: Can intense training affect my bloodwork results?

A: Absolutely. Heavy lifting can elevate AST, creatinine, and CK levels. Avoid intense training 48-72 hours before blood draws for accurate results.

Q: My HDL dropped to 28 mg/dL. Is this dangerous?

A: This is concerning and increases cardiovascular risk. Implement cardio exercise, omega-3 supplementation, and consider reducing compound dosages.

Q: Should I tell my doctor about research compound use?

A: Honest communication ensures proper medical care. Many physicians are becoming more knowledgeable about performance enhancement, especially in sports medicine.

Q: How long after stopping compounds should hormones normalize?

A: With proper PCT, LH/FSH typically recover within 6-12 weeks. However, complete hormonal normalization may take 3-6 months depending on protocol duration and compounds used.

Conclusion

Bloodwork literacy separates smart researchers from reckless users. Your blood panels provide objective data about compound effects, allowing evidence-based decisions about dosing, duration, and health interventions.

The small investment in regular testing prevents major health complications and optimizes both performance and recovery. Make bloodwork monitoring as routine as training and nutrition.

Ready to build your personalized research protocol based on your health markers? Get your free, customized plan at ProtocolHQ.com and take the guesswork out of compound selection and dosing.